Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process
To Best Facilitate, Company Voluntarily Files Chapter 11 Proceedings Company Has Sufficient Resources to Support…
News
Ascendis Pharma Showcases Commitment to Rare Endocrine Diseases at the 25th European Congress of Endocrinology 2023
COPENHAGEN, Denmark, May 13, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…
ASEAN strives to increase cooperation and reduce tensions in the region
JAKARTA, May 13, 2023 – (ACN Newswire) – President Joko Widodo (Jokowi) chaired two of…
Veritasi Homes Listed on Financial Times Africa’s Fastest Growing Companies 2023
Lagos, Nigeria–(Newsfile Corp. – May 13, 2023) – Veritasi Homes, a leading Nigerian real estate…
Blue Water Biotech Reports First Quarter 2023 Financial Results and Recent Business Highlights
CINCINNATI, May 12, 2023 (GLOBE NEWSWIRE) — Blue Water Biotech, Inc. (“Blue Water” or the…
RIWI Releases 2022 Audited Financials
Toronto, Ontario–(Newsfile Corp. – May 12, 2023) – RIWI Corp. (TSXV: RIWI) (OTC Pink: RWCRF)…
Forbes to be Acquired by Entrepreneur and Philanthropist Austin Russell
Sets vision to champion the next generation of capitalism with business-for-good and giving back NEW…
STEM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Stem, Inc. f/k/a Star Peak Energy Transition Corp. Investors with Substantial Losses Have Opportunity to Lead the Stem Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Stem,…
Aligos Therapeutics Announces Research Collaboration and Development Agreement with Xiamen Amoytop Biotech Co. Ltd. for Use of Aligos’ Oligonucleotide Platform for the Treatment of Liver Diseases
SOUTH SAN FRANCISCO, Calif., May 12, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS,…
InspireMD Announces May 16, 2023 as New Date for First Quarter 2023 Results Conference Call and Webcast
– Conference call and webcast to be held at 8:30 a.m. EDT – TEL AVIV,…
Jasper Therapeutics Reports First Quarter 2023 Financial Results and Provides a Business Update
Announced Planned Development Expansion of Briquilimab in Chronic Spontaneous Urticaria Presented Positive Follow-up Clinical Data…
Mustang Bio Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
WORCESTER, Mass., May 12, 2023 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a…
HilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
BOSTON, May 12, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
Clene Reports First Quarter 2023 Financial Results and Recent Operating Highlights
ALS biomarker and long-term clinical data expected mid-year Neurology expert Ben Greenberg, M.D., M.H.S., joined…
Hypercharge Issues Clarifying News Release and Announces Amended and Restated MD&A
Vancouver, British Columbia–(Newsfile Corp. – May 12, 2023) – Hypercharge Networks Corp. (NEO: HC) (OTCQB:…
Jasper Commerce Announces Stock Option Grant
Vancouver, British Columbia–(Newsfile Corp. – May 12, 2023) – Jasper Commerce Inc. (TSXV: JPIM) (“Jasper”…
American Aires Announces Closing of Private Placement
Toronto, Ontario–(Newsfile Corp. – May 12, 2023) – American Aires Inc. (CSE: WIFI) (OTC Pink:…
Procaps Group Reports Fourth Quarter and Full Year 2022 Results
Constant Currency Net Revenues Increased 7% Year-over-Year in 2022, With Strong Demand of RX and…
Cronos Group Inc. to Speak at the Canaccord Genuity 7th Annual Global Cannabis Conference
TORONTO, May 12, 2023 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”…
Cronos Group Inc. to Speak at the Canaccord Genuity 7th Annual Global Cannabis Conference
TORONTO, May 12, 2023 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”…